Sigma Planning Corp reduced its position in shares of HCA Healthcare Inc (NYSE:HCA) by 51.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,821 shares of the company’s stock after selling 1,958 shares during the quarter. Sigma Planning Corp’s holdings in HCA Healthcare were worth $227,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. FMR LLC lifted its position in HCA Healthcare by 98.7% during the third quarter. FMR LLC now owns 10,907,407 shares of the company’s stock worth $1,517,438,000 after purchasing an additional 5,419,134 shares during the period. AQR Capital Management LLC grew its position in shares of HCA Healthcare by 433.7% during the 3rd quarter. AQR Capital Management LLC now owns 1,293,241 shares of the company’s stock worth $179,916,000 after buying an additional 1,050,940 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of HCA Healthcare by 98.3% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,767,715 shares of the company’s stock worth $245,925,000 after buying an additional 876,226 shares during the period. Point72 Asset Management L.P. grew its position in HCA Healthcare by 547.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 873,660 shares of the company’s stock valued at $121,544,000 after purchasing an additional 738,660 shares during the period. Finally, Acadian Asset Management LLC grew its position in HCA Healthcare by 213.7% in the 3rd quarter. Acadian Asset Management LLC now owns 645,679 shares of the company’s stock valued at $89,830,000 after purchasing an additional 439,826 shares during the period. Hedge funds and other institutional investors own 72.85% of the company’s stock.
HCA has been the subject of several recent research reports. Zacks Investment Research lowered HCA Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, November 20th. Argus boosted their target price on HCA Healthcare from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Tuesday, November 6th. Oppenheimer boosted their price objective on HCA Healthcare from $142.00 to $150.00 and gave the company an “outperform” rating in a research report on Wednesday, January 30th. Stephens assumed coverage on HCA Healthcare in a report on Monday, January 14th. They set an “overweight” rating and a $143.00 target price for the company. Finally, UBS Group initiated coverage on HCA Healthcare in a research note on Thursday, November 15th. They issued a “buy” rating and a $162.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and eighteen have issued a buy rating to the stock. HCA Healthcare presently has an average rating of “Buy” and an average price target of $148.43.
HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 29th. The company reported $2.99 EPS for the quarter, topping the consensus estimate of $2.59 by $0.40. The firm had revenue of $12.27 billion during the quarter, compared to analysts’ expectations of $12.10 billion. HCA Healthcare had a net margin of 8.11% and a negative return on equity of 91.25%. HCA Healthcare’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.12 EPS. Equities analysts expect that HCA Healthcare Inc will post 10.02 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 1st will be given a $0.40 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.35. The ex-dividend date is Thursday, February 28th. This represents a $1.60 dividend on an annualized basis and a yield of 1.15%. HCA Healthcare’s dividend payout ratio is presently 14.33%.
In related news, SVP Victor L. Campbell sold 28,084 shares of HCA Healthcare stock in a transaction dated Monday, February 11th. The shares were sold at an average price of $138.97, for a total transaction of $3,902,833.48. Following the completion of the transaction, the senior vice president now directly owns 231,493 shares of the company’s stock, valued at approximately $32,170,582.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP J William Morrow sold 263 shares of the firm’s stock in a transaction dated Thursday, February 7th. The shares were sold at an average price of $140.60, for a total transaction of $36,977.80. Following the completion of the sale, the senior vice president now owns 5,922 shares of the company’s stock, valued at approximately $832,633.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 29,336 shares of company stock valued at $4,077,257. Insiders own 2.80% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Sigma Planning Corp Cuts Stake in HCA Healthcare Inc (HCA)” was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4146132/sigma-planning-corp-cuts-stake-in-hca-healthcare-inc-hca.html.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Read More: How to read a candlestick chart
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.